Alternative synthesis of the anti-baldness compound RU58841
January 2014
in “RSC Advances”

TLDR
A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.
In 2014, researchers developed a new synthesis method for the anti-baldness compound RU58841, which was more efficient and less toxic than the previous method. The old method used phosgene, a toxic gas, and required multiple steps under an inert atmosphere and flash chromatography. The new method did not use phosgene, required only one inert atmosphere step, and did not require flash chromatography. The overall yield of the new synthesis was 33%. The researchers also found that bromine-nitro substitutions can occur on tertiary carbons with a neighboring carbonyl, and that 2-nitropropane can be an effective leaving group, enabling the formation of a hydantoin ring by cyclization.
View this study on pubs.rsc.org →
Cited in this study

research A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice
RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

research Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite
Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

research RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism
RU 58841 may treat acne, hair loss, and excessive hair growth.